Latest California Healthline Stories
In May 2021, Lags Medical Centers, one of California’s largest chains of pain clinics, abruptly closed its doors amid a cloaked state investigation. Nine months later, patients are still in the dark about what happened with their care and to their bodies.
KHN’s ‘What the Health?’: It’s Health Costs, Stupid (2022 Edition)
As the pandemic wanes, for now, the ever-rising cost of health care is again taking center stage. Meanwhile, a year into the Biden administration, the FDA finally has a Senate-confirmed commissioner, Dr. Robert Califf. Tami Luhby of CNN, Sarah Karlin-Smith of the Pink Sheet, and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Hannah Wesolowski of the National Alliance on Mental Illness, about how the pandemic has worsened the nation’s mental health crisis and what can be done about it.
Inside the Tactical Tug of War Over the Controversial Alzheimer’s Drug
An epic battle is playing out behind the scenes over whether the government should pay for Aduhelm, an FDA-approved Alzheimer’s drug that scientists say has not been proven to work.
This Doctor Thought She Could Navigate US Health Care. Then Her Autistic Son Needed Help.
Dr. Mai Pham left her corporate career to spark change in a system that is failing millions of Americans with autism and other intellectual and developmental disabilities.
Medical Boards Pressured to Let It Slide When Doctors Spread Covid Misinformation
State medical boards have an obligation to investigate complaints about doctors, including those who may spread false information about medical care. But in Florida, Tennessee, and other states, lawmakers are moving to protect physicians using unproven covid treatments or spreading misinformation.
KHN’s ‘What the Health?’: FDA Takes Center Stage
Congress is set to start its once-every-five-years review of the law that authorizes user fees to finance the hiring of personnel to speed the FDA review of drugs. The periodic renewals of “PDUFA” also give lawmakers a chance to make other changes to the agency at the hub of the pandemic. Meanwhile, the FDA could also find itself at the center of the abortion debate and a controversial new medication to treat Alzheimer’s disease. Anna Edney of Bloomberg News, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more.
Federal Investigation Into Spine Surgeries Uses Mob Laws to Target Health Care Fraud
Investigators allege a Texas company that arranges spine surgery and other medical care for people injured in car crashes accepted bribes in violation of 1960s-era racketeering law.
Health Care Paradox: Medicare Penalizes Dozens of Hospitals It Also Gives Five Stars
Among the 764 hospitals hit with a 1% reduction in Medicare payments this year for having high numbers of patient infections and avoidable complications are more than three dozen that Medicare also ranks as among the best in the country, including Cedar-Sinai Medical Center in Los Angeles.
Bounties and Bonuses Leave Small Hospitals Behind in Staffing Wars
A hospital in Wisconsin sued to keep seven employees from taking jobs with a competitor. A health system in South Dakota is offering nurses $40,000 signing bonuses. Facilities with fewer resources are finding it difficult or impossible to compete for health care workers.
State Inks Sweetheart Deal With Kaiser Permanente, Jeopardizing Medicaid Reforms
The backroom deal with politically connected Kaiser Permanente, which infuriated other Medi-Cal health plans, allows the health care giant to continue selecting the enrollees it wants.